We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Researchers Use Natural-Language Processing (NLP) Algorithms to Predict SARS-CoV-2 Virus Mutations

By LabMedica International staff writers
Posted on 18 Jan 2021
Natural-language processing (NLP) algorithms are now able to generate protein sequences and predict virus mutations, including key changes that help the SARS-CoV-2 virus evade the immune system.

The key insight making this possible is that many properties of biological systems can be interpreted in terms of words and sentences. More...
In the last few years, a handful of researchers have shown that protein sequences and genetic codes can be modeled using NLP techniques. Now, computational biologists at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) have pulled several of these strands together and use NLP to predict mutations that allow viruses to avoid being detected by antibodies in the human immune system, a process known as viral immune escape. The basic idea is that the interpretation of a virus by an immune system is analogous to the interpretation of a sentence by a human.

The team uses two different linguistic concepts: grammar and semantics (or meaning). The genetic or evolutionary fitness of a virus - characteristics such as how good it is at infecting a host - can be interpreted in terms of grammatical correctness. A successful, infectious virus is grammatically correct; an unsuccessful one is not. Similarly, mutations of a virus can be interpreted in terms of semantics. Mutations that make a virus appear different to things in its environment - such as changes in its surface proteins that make it invisible to certain antibodies - have altered its meaning. Viruses with different mutations can have different meanings, and a virus with a different meaning may need different antibodies to read it.

To model these properties, the researchers used an LSTM, a type of neural network that predates the transformer-based ones used by large language models like GPT-3. These older networks can be trained on far less data than transformers and still perform well for many applications. Instead of millions of sentences, they trained the NLP model on thousands of genetic sequences taken from three different viruses: 45,000 unique sequences for a strain of influenza, 60,000 for a strain of HIV, and between 3,000 and 4,000 for a strain of the SARS-CoV-2 virus.

NLP models work by encoding words in a mathematical space in such a way that words with similar meanings are closer together than words with different meanings. This is known as an embedding. For viruses, the embedding of the genetic sequences grouped viruses according to how similar their mutations were. The overall aim of the approach is to identify mutations that might let a virus escape an immune system without making it less infectious - that is, mutations that change a virus’s meaning without making it grammatically incorrect.

To test their approach, the team used a common metric for assessing predictions made by machine-learning models that scores accuracy on a scale between 0.5 (no better than chance) and 1 (perfect). In this case, they took the top mutations identified by the tool and, using real viruses in a lab, checked how many of them were actual escape mutations. Their results ranged from 0.69 for HIV to 0.85 for one coronavirus strain. This is better than results from other state-of-the-art models, according to the researchers.

The team has been running models on new variants of the coronavirus, including the so-called UK mutation, the mink mutation from Denmark, and variants taken from South Africa, Singapore and Malaysia. Using NLP accelerates a slow process. Previously, the genome of the virus taken from a COVID-19 patient in hospital could be sequenced and its mutations re-created and studied in a lab. However, that can take weeks, whereas the NLP model predicts potential mutations straight away, which focuses the lab work and speeds it up.

“We’re learning the language of evolution,” said Bonnie Berger, a computational biologist at the Massachusetts Institute of Technology. “Biology has its own language.”

Related Links:
Massachusetts Institute of Technology (MIT)


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.